Cellegy Resubmits Cellegesic NDA For Anal Fissure Pain
This article was originally published in The Pink Sheet Daily
Executive Summary
NDA includes three pivotal trials for nitroglycerin ointment; the third trial was conducted under special protocol assessment after withdrawal of the original NDA in 2002. Cellegy has requested priority review.